Quantitative Analysis of Cyclin Dl Messenger RNA Expression in Head and Neck Squamous Cell Carcinomas

por Monden, Nobuya, Nishizaki, Kazunori, Fukushima, Kunihiro, Masuda, Yu, Tsukuda, Kazunori, Shimizu, Kenji
Publicado 1997

Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib

por Hashida, Shinsuke, Yamamoto, Hiromasa, Shien, Kazuhiko, Miyoshi, Yuichiro, Ohtsuka, Tomoaki, Suzawa, Ken, Watanabe, Mototsugu, Maki, Yuho, Soh, Junichi, Asano, Hiroaki, Tsukuda, Kazunori, Miyoshi, Shinichiro, Toyooka, Shinichi
Publicado 2015

Antitumor activity of pan‐HER inhibitors in HER2‐positive gastric cancer

por Yoshioka, Takahiro, Shien, Kazuhiko, Namba, Kei, Torigoe, Hidejiro, Sato, Hiroki, Tomida, Shuta, Yamamoto, Hiromasa, Asano, Hiroaki, Soh, Junichi, Tsukuda, Kazunori, Nagasaka, Takeshi, Fujiwara, Toshiyoshi, Toyooka, Shinichi
Publicado 2018

DNA methylation status of REIC/Dkk-3 gene in human malignancies

por Hayashi, Tatsuro, Asano, Hiroaki, Toyooka, Shinichi, Tsukuda, Kazunori, Soh, Junichi, Shien, Tadahiko, Taira, Naruto, Maki, Yuho, Tanaka, Norimitsu, Doihara, Hiroyoshi, Nasu, Yasutomo, Huh, Nam-ho, Miyoshi, Shinichiro
Publicado 2012

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations

por Suzawa, Ken, Toyooka, Shinichi, Sakaguchi, Masakiyo, Morita, Mizuki, Yamamoto, Hiromasa, Tomida, Shuta, Ohtsuka, Tomoaki, Watanabe, Mototsugu, Hashida, Shinsuke, Maki, Yuho, Soh, Junichi, Asano, Hiroaki, Tsukuda, Kazunori, Miyoshi, Shinichiro
Publicado 2015

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features

por Sato, Hiroki, Shien, Kazuhiko, Tomida, Shuta, Okayasu, Kazuhiro, Suzawa, Ken, Hashida, Shinsuke, Torigoe, Hidejiro, Watanabe, Mototsugu, Yamamoto, Hiromasa, Soh, Junichi, Asano, Hiroaki, Tsukuda, Kazunori, Miyoshi, Shinichiro, Toyooka, Shinichi
Publicado 2017

Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations

por Torigoe, Hidejiro, Shien, Kazuhiko, Takeda, Tatsuaki, Yoshioka, Takahiro, Namba, Kei, Sato, Hiroki, Suzawa, Ken, Yamamoto, Hiromasa, Soh, Junichi, Sakaguchi, Masakiyo, Tomida, Shuta, Tsukuda, Kazunori, Miyoshi, Shinichiro, Toyooka, Shinichi
Publicado 2018

Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas

por Yamamoto, Hiromasa, Higasa, Koichiro, Sakaguchi, Masakiyo, Shien, Kazuhiko, Soh, Junichi, Ichimura, Koichi, Furukawa, Masashi, Hashida, Shinsuke, Tsukuda, Kazunori, Takigawa, Nagio, Matsuo, Keitaro, Kiura, Katsuyuki, Miyoshi, Shinichiro, Matsuda, Fumihiko, Toyooka, Shinichi
Publicado 2013

Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma

por Namba, Kei, Tomida, Shuta, Matsubara, Takehiro, Takahashi, Yuta, Kurihara, Eisuke, Ogoshi, Yusuke, Yoshioka, Takahiro, Takeda, Tatsuaki, Torigoe, Hidejiro, Sato, Hiroki, Shien, Kazuhiko, Yamamoto, Hiromasa, Soh, Junichi, Tsukuda, Kazunori, Toyooka, Shinichi
Publicado 2019

Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer

por Shien, Kazuhiko, Tanaka, Norimitsu, Watanabe, Masami, Soh, Junichi, Sakaguchi, Masakiyo, Matsuo, Keitaro, Yamamoto, Hiromasa, Furukawa, Masashi, Asano, Hiroaki, Tsukuda, Kazunori, Nasu, Yasutomo, Huh, Nam-Ho, Miyoshi, Shinichiro, Kumon, Hiromi, Toyooka, Shinichi
Publicado 2014

TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells

por Otani, Hiroki, Yamamoto, Hiromasa, Takaoka, Munenori, Sakaguchi, Masakiyo, Soh, Junichi, Jida, Masaru, Ueno, Tsuyoshi, Kubo, Takafumi, Asano, Hiroaki, Tsukuda, Kazunori, Kiura, Katsuyuki, Hatakeyama, Shinji, Kawahara, Eiji, Naomoto, Yoshio, Miyoshi, Shinichiro, Toyooka, Shinichi
Publicado 2015

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma

por Sato, Hiroki, Sakaguchi, Masakiyo, Yamamoto, Hiromasa, Tomida, Shuta, Aoe, Keisuke, Shien, Kazuhiko, Yoshioka, Takahiro, Namba, Kei, Torigoe, Hidejiro, Soh, Junichi, Tsukuda, Kazunori, Tao, Hiroyuki, Okabe, Kazunori, Miyoshi, Shinichiro, Pass, Harvey I., Toyooka, Shinichi
Publicado 2018

The proliferative effects of asbestos-exposed peripheral blood mononuclear cells on mesothelial cells

por MAKI, YUHO, NISHIMURA, YASUMITSU, TOYOOKA, SHINICHI, SOH, JUNICHI, TSUKUDA, KAZUNORI, SHIEN, KAZUHIKO, FURUKAWA, MASASHI, MURAOKA, TAKAYUKI, UENO, TSUYOSHI, TANAKA, NORIMITSU, YAMAMOTO, HIROMASA, ASANO, HIROAKI, MAEDA, MEGUMI, KUMAGAI-TAKEI, NAOKO, LEE, SUNI, MATSUZAKI, HIDENORI, OTSUKI, TAKEMI, MIYOSHI, SHINICHIRO
Publicado 2016

Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway

por Ohtsuka, Tomoaki, Sakaguchi, Masakiyo, Yamamoto, Hiromasa, Tomida, Shuta, Takata, Katsuyoshi, Shien, Kazuhiko, Hashida, Shinsuke, Miyata-Takata, Tomoko, Watanabe, Mototsugu, Suzawa, Ken, Soh, Junichi, Youyi, Chen, Sato, Hiroki, Namba, Kei, Torigoe, Hidejiro, Tsukuda, Kazunori, Yoshino, Tadashi, Miyoshi, Shinichiro, Toyooka, Shinichi
Publicado 2016

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

por Takeda, Tatsuaki, Yamamoto, Hiromasa, Kanzaki, Hirotaka, Suzawa, Ken, Yoshioka, Takahiro, Tomida, Shuta, Cui, Xiaojiang, Murali, Ramachandran, Namba, Kei, Sato, Hiroki, Torigoe, Hidejiro, Watanabe, Mototsugu, Shien, Kazuhiko, Soh, Junichi, Asano, Hiroaki, Tsukuda, Kazunori, Kitamura, Yoshihisa, Miyoshi, Shinichiro, Sendo, Toshiaki, Toyooka, Shinichi
Publicado 2017